Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1110501

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1110501

Dermal Filler Market (Product: Biodegradable & Non-biodegradable; Material: Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-lactic Acid, PMMA, Fat, & Others) - U.S. Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2022-2031

PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

The report provides revenue of the dermal filler market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of dermal filler market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the dermal filler market in U.S..

The report delves into the competitive landscape of the dermal filler market. Key players operating in the dermal filler market in U.S. have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the dermal filler market profiled in this report.

Product Code: TMRGL84816

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: U.S. Dermal Fillers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. U.S. Dermal Fillers Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Regulatory Scenario in the U.S.
  • 5.3. Licensing Agreement Analysis
  • 5.4. COVID-19 Impact Analysis

6. U.S. Dermal Fillers Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Biodegradable
    • 6.3.2. Non-biodegradable
  • 6.4. Market Attractiveness Analysis, by Product

7. U.S. Dermal Fillers Market Analysis and Forecast, by Material

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Material, 2017-2031
    • 7.3.1. Calcium Hydroxylapatite
    • 7.3.2. Hyaluronic Acid
    • 7.3.3. Collagen
    • 7.3.4. Poly-L-Lactic Acid
    • 7.3.5. Polymethylmethacrylate (PMMA)
    • 7.3.6. Fat
    • 7.3.7. Others
  • 7.4. Market Attractiveness Analysis, by Material

8. U.S. Dermal Fillers Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Facial Line Correction Treatment
    • 8.3.2. Lip Enhancement
    • 8.3.3. Scar Treatment
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. U.S. Dermal Fillers Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Dermatology Clinics
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Competition Landscape

  • 10.1. Market Player - Competition Matrix (by tier and size of companies)
  • 10.2. Market Share Analysis, by Company, 2020
  • 10.3. Company Profiles
    • 10.3.1. AbbVie
      • 10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.1.2. Product Portfolio
      • 10.3.1.3. SWOT Analysis
      • 10.3.1.4. Strategic Overview
    • 10.3.2. Advanced Aesthetic Technologies, Inc.
      • 10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.2.2. Product Portfolio
      • 10.3.2.3. SWOT Analysis
      • 10.3.2.4. Strategic Overview
    • 10.3.3. Anika Therapeutics, Inc.
      • 10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.3.2. Product Portfolio
      • 10.3.3.3. SWOT Analysis
      • 10.3.3.4. Strategic Overview
    • 10.3.4. BioPlus Co., Ltd.
      • 10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.4.2. Product Portfolio
      • 10.3.4.3. SWOT Analysis
      • 10.3.4.4. Strategic Overview
    • 10.3.5. Croma-Pharma GmbH
      • 10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.5.2. Product Portfolio
      • 10.3.5.3. SWOT Analysis
      • 10.3.5.4. Strategic Overview
    • 10.3.6. Cytophil, Inc.
      • 10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.6.2. Product Portfolio
      • 10.3.6.3. SWOT Analysis
      • 10.3.6.4. Strategic Overview
    • 10.3.7. DR. Korman Laboratories.
      • 10.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.7.2. Product Portfolio
      • 10.3.7.3. SWOT Analysis
      • 10.3.7.4. Strategic Overview
    • 10.3.8. Galderma
      • 10.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.8.2. Product Portfolio
      • 10.3.8.3. SWOT Analysis
      • 10.3.8.4. Strategic Overview
    • 10.3.9. Huons USA
      • 10.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.9.2. Product Portfolio
      • 10.3.9.3. SWOT Analysis
      • 10.3.9.4. Strategic Overview
    • 10.3.10. Merz Pharma GmbH & Co. KGaA
      • 10.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.10.2. Product Portfolio
      • 10.3.10.3. SWOT Analysis
      • 10.3.10.4. Strategic Overview
    • 10.3.11. Revance
      • 10.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.11.2. Product Portfolio
      • 10.3.11.3. SWOT Analysis
      • 10.3.11.4. Strategic Overview
    • 10.3.12. Sinclair Pharma
      • 10.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.12.2. Product Portfolio
      • 10.3.12.3. SWOT Analysis
      • 10.3.12.4. Strategic Overview
    • 10.3.13. Suneva Medical, Inc.
      • 10.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.13.2. Product Portfolio
      • 10.3.13.3. SWOT Analysis
      • 10.3.13.4. Strategic Overview
    • 10.3.14. Syneron Medical Ltd.
      • 10.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.14.2. Product Portfolio
      • 10.3.14.3. SWOT Analysis
      • 10.3.14.4. Strategic Overview
    • 10.3.15. TEOXANE Laboratories
      • 10.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 10.3.15.2. Product Portfolio
      • 10.3.15.3. SWOT Analysis
      • 10.3.15.4. Strategic Overview
Product Code: TMRGL84816

List of Tables

  • Table 01: U.S. Dermal Filler Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: U.S. Dermal Filler Market Revenue (US$ Mn) Forecast, by Material, 2017-2031
  • Table 03: U.S. Dermal Filler Market Revenue (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: U.S. Dermal Filler Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: U.S. Dermal Filler Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: U.S. Dermal Filler Market Value Share, by Product, 2020
  • Figure 03: U.S. Dermal Filler Market Value Share, Material, 2020
  • Figure 04: U.S. Dermal Filler Market Value Share, by Application, 2020
  • Figure 05: U.S. Dermal Filler Market Value Share, End-user, 2020
  • Figure 06: U.S. Dermal Filler Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 07: U.S. Dermal Filler Market Revenue (US$ Mn), by Biodegradable, 2017-2031
  • Figure 08: U.S. Dermal Filler Market Revenue (US$ Mn), by Non-biodegradable, 2017-2031
  • Figure 09: U.S. Dermal Filler Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 10: U.S. Dermal Filler Market Attractiveness Analysis, by Material, 2021-2031
  • Figure 11: U.S. Dermal Filler Market Revenue (US$ Mn), by Calcium Hydroxylapatite, 2017-2031
  • Figure 12: U.S. Dermal Filler Market Revenue (US$ Mn), by Hyaluronic Acid, 2017-2031
  • Figure 13: U.S. Dermal Filler Market Revenue (US$ Mn), by Collagen, 2017-2031
  • Figure 14: U.S. Dermal Filler Market Revenue (US$ Mn), by Poly-L-lactic Acid, 2017-2031
  • Figure 15: U.S. Dermal Filler Market Revenue (US$ Mn), by PMMA, 2017-2031
  • Figure 16: U.S. Dermal Filler Market Revenue (US$ Mn), by Fat, 2017-2031
  • Figure 17: U.S. Dermal Filler Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 18: U.S. Dermal Filler Market Attractiveness Analysis, by Material, 2021-2031
  • Figure 19: U.S. Dermal Filler Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 20: U.S. Dermal Filler Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 21: U.S. Dermal Filler Market Revenue (US$ Mn), by Facial Line Correction Treatment, 2017-2031
  • Figure 22: U.S. Dermal Filler Market Revenue (US$ Mn), by Lip Enhancement, 2017-2031
  • Figure 23: U.S. Dermal Filler Market Revenue (US$ Mn), by Scar Treatment, 2017-2031
  • Figure 24: U.S. Dermal Filler Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 25: U.S. Dermal Filler Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 26: U.S. Dermal Filler Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 27: U.S. Dermal Filler Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 28: U.S. Dermal Filler Market Revenue (US$ Mn), by Dermatology Clinics, 2017-2031
  • Figure 29: U.S. Dermal Filler Market Revenue (US$ Mn), by Aesthetic Centers, 2017-2031
  • Figure 30: U.S. Dermal Filler Market Revenue (US$ Mn), by Others, 2017-2031
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!